FPF
TEVA icon

FNY Partners Fund’s Teva Pharmaceuticals TEVA Stock Holding History

FNY Partners Fund’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$17K Buy
+1,000
New +$19.5K 0.01% 247
2017
Q2 		– Sell
-900
Closed -$28K – 1101
2017
Q1 		$28K Buy
900
+400
+80% +$13.7K ﹤0.01% 871
2016
Q4 		$18K Buy
+500
New +$20K ﹤0.01% 385

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FNY Partners Fund's TEVA Position: Q1 2018 in Review

FNY Partners Fund opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2018: 1,000 shares worth $17K. The stake represents 0.01% of the portfolio and ranks #247 among its holdings. This is a return to the name: FNY Partners Fund previously reported a position in TEVA as recently as Q1 2017.

FNY Partners Fund first reported a position in TEVA in Q4 2016 and has held it in 3 quarters since. The position peaked at $28K in Q1 2017. 507 funds tracked by Wall St. Rank hold TEVA as of Q1 2018.

  • FNY Partners Fund held 1,000 shares of Teva Pharmaceuticals worth $17K as of Q1 2018.
  • Teva Pharmaceuticals was a new FNY Partners Fund position in Q1 2018.
  • Teva Pharmaceuticals made up 0.01% of FNY Partners Fund's portfolio in Q1 2018, its #247 holding.
  • FNY Partners Fund first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 3 quarters since.
  • FNY Partners Fund's Teva Pharmaceuticals position peaked at $28K in Q1 2017.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.